Last reviewed · How we verify
NCT05189847: KAMMA
Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis
trial in Polyvascular Disease in 3,059 participants. Completed in 31 January 2024.
31 January 2024
Quick facts
| Lead sponsor | Eurasian Association of Therapists |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,059 |
| Start date | 1 February 2022 |
| Primary completion | 31 January 2024 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across Russia |
Conditions studied
- Polyvascular Disease — all drugs for Polyvascular Disease →
- Atherosclerosis — all drugs for Atherosclerosis →
- Atherosclerosis Generalized — all drugs for Atherosclerosis Generalized →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Eurasian Association of Therapists
Who can join
18 and older, any sex, with Polyvascular Disease or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Аn international, multicenter, non-interventional real-life clinical practice Register studying the Actual therapeutic patient population with Multifocal Atherosclerosis in the Russian Federation and Eurasian countries
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05189847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polyvascular Disease
Currently open trials in the same condition.
- NCT06231966 — Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target · NA · recruiting
- NCT06016608 — An Imaging Study of Polyvascular Disease · recruiting
Other Eurasian Association of Therapists trials
Trials by the same sponsor.
- NCT05690009 — Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease · completed
- NCT04295057 — Register of Therapeutical Patients Over 60 Years · unknown
- NCT05226416 — Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection · completed
- NCT04709120 — Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection · completed
- NCT04492384 — Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05189847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eurasian Association of Therapists
- Last refreshed: 26 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05189847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing